Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

导出 OA

翻译打印收藏纠错

第一作者： Alexander,Schuhmacher

第一单位： Reutlingen University, Alteburgstrasse 150, 72762, Reutlingen, Germany. alexander.schuhmacher@reutlingen-university.de.

作者： Alexander,Schuhmacher ^[1] ; Oliver,Gassmann ^[2] ; Nigel,McCracken ^[3] ; Markus,Hinder ^[4]

作者单位： Reutlingen University, Alteburgstrasse 150, 72762, Reutlingen, Germany. alexander.schuhmacher@reutlingen-university.de. ^[1] Institute for Technology Management, University of St. Gallen, Dufourstrasse 40a, 9000, St. Gallen, Switzerland. ^[2] Debiopharm International S.A., Chemin Messidor 5-7, 1002, Lausanne, Switzerland. ^[3] Novartis Institutes for BioMedical Research, Postfach, Forum 1, 4002, Basel, Switzerland. ^[4]

关键词 Crowdsourcing Knowledge leverager Open innovation Pharmaceutical industry Public–private partnerships

主题词决策(Decision Making);制药工业(Drug Industry);知识(Knowledge);研究(Research)

DOI 10.1186/s12967-018-1499-2

PMID 29739427

发布时间 2019-07-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交